Greeting! I am Kim, Min Gyu, the CEO of MK biotech.
MK biotech is a leading bio-tech company to research disease model animals and transgenic animals to produce useful proteins as a new medicine for improving the life quality and longevity of human
MK biotech aims to overcome intractable diseases through the production of disease model animals to search and test therapeutical treatments and transgenic cloned animals to develop new drugs of degenerative diseases which have been a problematic issue in the aging society.
The key technologies in MK biotech have been recognized by the development of degenerative disease model animals and transgenic cloned animals to produce a therapeutic antibody of rheumatoid arthritis. In addition, MK biotech has been tried to fulfill the social obligation as a biotechnology company by providing cloned dogs such as drug detection dogs and police dogs (K-9).
MK biotech pursues to fulfill the dream of advanced biotechnology which is to lead the development of scientific technology and improvement of human well-being.